CNP and metabolic dysfunction-associated steatohepatitis: However, our data reveal a clear reduction in plasma CNP concentrations in patients with MASH cirrhosis compared with controls without overt liver disease and, in addition, that patients with decompensated cirrhosis with evidence of portal hypertension have significantly reduced circulating levels of CNP compared with patients with compensated cirrhosis.